title: FDA notifications. New guidance assists HIV drug development. Changes affect approvals for antiretroviral drugs.
abstract: The Food and Drug Administration has issued new guidance intended to assist sponsors in the clinical development of drugs for the treatment of HIV infection.
mesh_terms: D019380:Anti-HIV Agents; D018791:CD4 Lymphocyte Count; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004352:Drug Resistance, Microbial; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration; D019562:Viral Load
chemical_list: D019380:Anti-HIV Agents